MHRA approves self-inject treatment for relapsing MS

Latest

MHRA approves self-inject treatment for relapsing MS

In Latest

 

The MHRA has approved ofatumumab for adult patients with relapsing forms of multiple sclerosis (RMS), manufacturer Novartis has announced. 

The self-administered targeted B-cell depleting treatment, which is marketed as Kesimpta, is one of the first drugs to be granted a UK marketing authorisation since the UK’s departure from the European Union.

The licence is based on two Phase III studies in which it demonstrated a “significant reduction” in relapses per year versus teriflunomide tablets among patients with active RMS.

Ofatumumab allows faster repletion of B cells than other anti-CD20 monoclonal antibodies and may “offer flexibility in the management of RMS,” said Novartis. 

Patients with active RMS who are prescribed ofatumumab administer the treatment themselves at home once a month after receiving initial guidance from a healthcare professional.

NICE and the Scottish Medicine Consortium are expected to publish their advice on the medicine later this year. 

Fredi Cavander-Attwood, policy manager at the MS Society, says: “It’s positive news that ofatumumab – a self-injecting disease modifying treatment (DMT) – has been given a MHRA licence for use in people with active relapsing remitting multiple sclerosis (MS). More than 130,000 people live with MS in the UK, and many still don’t have access to a treatment that works for them. 

“MS is relentless, painful and disabling, and people with MS often tell us about the convenience of being able to have a DMT at home instead of in hospital. For working age adults, self-injecting ofatumumab could alleviate the challenge of having to frequently take time out of work to attend appointments.

“We now await the provisional decisions on the approval of ofatumumab by NICE and the SMC for use on the NHS.”

Chinmay Bhatt of Novartis said: “Ofatumumab demonstrates our commitment to reimagining medicine and we will work closely with all UK stakeholders to ensure eligible patients can start benefitting rom this treatment as quickly as possible.”

 

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

Rowlands’ losses more than double ‘due to Category M changes’

Rowlands attributes a £71.3m financial loss to Government decisions including changes to Category M reimbursement prices. 

1 Min Article

bookmark_icon_off
Latest

Number of pre-regs to GP practices through split scheme rises

A split pre-reg scheme has increased the number of trainees to surgeries this year.

1 Min Article

bookmark_icon_off
Latest

Well Pharmacy CEO to retire

Well Pharmacy CEO John Nuttall is to retire on September 30.

1 Min Article

bookmark_icon_off
Latest

Regulators issue principles for online prescribing

The jointly-agreed 10 high level principles set out the good practice expected when prescribing medication online.

1 Min Article

bookmark_icon_off
Latest

Contractors ‘should review test & trace readiness’

Pharmacy owners should carry out risk assessments and review their business continuity plans to prevent closures, says the GPhC.

1 Min Article

bookmark_icon_off
Latest

COVID-19: What should I do if I have to close?

Legal firm Charles Russell Speechlys advises on what to do if a pharmacy is unable to open due to the coronavirus outbreak.

1 Min Article

Recommended Learning

bookmark_icon_off
Sponsored education

Skincare training for pharmacy

Delve into dry skin management and understand how you can make a difference to customers looking for advice, support and product recommendations to help manage their compromised skin.

15 Min Module

bookmark_icon_off
Sponsored education

Helping customers treat & care for their scalp

Understanding the causes and symptoms of some common scalp conditions will help you to make a real difference to your customers’ lives. Complete this module to discover self-care and product advice to help ease symptoms and maintain scalp health.

10 Min Module

bookmark_icon_off
Sponsored education

Frontline Tackling Fleas & Ticks

This NPA-accredited module will enable you to have confident conversations with customers, helping them manage fleas and ticks both on their pets and in the home.

10 Min Module

bookmark_icon_off
Sponsored education

Confident pet health conversations

Learn 3 key steps to having more confident conversations with customers about pet health products.

3 Min Module

bookmark_icon_off
Bayer Business Programme

Make it Count: Team Member version

Find out new insights into the consumers of today and explore how, by taking a customer-first approach, you can add value and help build a loyal customer base.

15 Min Module

bookmark_icon_off
Sponsored education

Understanding constipation treatments

Discover the key benefits of different types of laxatives, and the right questions to ask customers to ensure you know which to recommend

10 Min Module